Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Kyowa Kirin Limited, Galabank Business Park, Galashiels, TD1 1QH, United Kingdom
Nardil tablets.
Pharmaceutical Form |
---|
Film coated tablet. |
Phenelzine sulphate BP equivalent to phenelzine base 15mg.
Active Ingredient | Description | |
---|---|---|
Phenelzine |
Phenelzine is an irreversible non-selective inhibitor of monoamine oxidase. Although the exact mechanism of action has not been determined, it appears that the irreversible, nonselective inhibition of MAO by phenelzine relieves depressive symptoms by causing an increase in the levels of serotonin, norepinephrine, and dopamine in the neuron. Phenelzine is used for the treatment of major depressive disorder. Has also been used with some success in the management of bulimia nervosa. |
List of Excipients |
---|
The tablet cores also contain mannitol, povidone, magnesium stearate and maize starch. The tablet coating contains hydroxypropyl cellulose, polyvinylacetatephthalate, stearic acid, sunset yellow (E110), titanium dioxide (E171), erythrosine (E127) hydroxypropylmethylcellulose (E464) and talc. |
White, high density polyethylene bottle fitted with a white, high density, polyethylene child resistant, tamper evident cap with expanded polyethylene liner, containing 100 tablets.
Kyowa Kirin Limited, Galabank Business Park, Galashiels, TD1 1QH, United Kingdom
PL 16508/0052
July 1999 / April 2001
Drug | Countries | |
---|---|---|
NARDIL | Australia, Canada, Estonia, Netherlands, New Zealand, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.